Article Information
Published By
Online ISSN
History
- Received October 23, 2020
- Accepted January 31, 2021
- Published online February 18, 2021.
Article Versions
- You are currently viewing a previous version of this article (February 18, 2021 - 10:46).
- View the most recent version of this article
Copyright & Usage
©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- 1Evidence Based Medical Educator, Toronto, Canada
- 2AstraZeneca, Mississauga, Canada
- 3Department of Medicine, University of Montreal, Quebec, Canada
- 4University of Toronto, Toronto, Canada
- 5Department of Health Research Methods, Evidence and Impact (HEI), McMaster University, Hamilton, Canada
- Stephen Noorduyn, Medical Evidence Team, Scientific Affairs, AstraZeneca Canada, 1004 Middlegate Road, Mississauga, ON, L4Y 1M4 Canada. E-Mail: Stephen.noorduyn{at}astrazeneca.com
Funding
AstraZeneca Canada